GALWAY, IRELAND--January 21, 2025--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharma major Novo Nordisk A/S (NYSE:NVO) (Bagsværd, Denmark) has announced that it is investing 8.5 billion Danish kroner (US$1.2 billion) to build a new production facility in Odense, Denmark. Within this article: Details investment by Novo Nordisk in a new manufacturing plant in Denmark, scale, timeline, success of Ozempic and Wegovy drugs and the impact on its fortunes and related manufacturing investments
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
